| 2025年中报 | 2024年年报 | 2023年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 非临床CRO(元) | 361,375,678.64 | 1,089,395,105.58 | 999,497,449.62 |
| 临床CRO(元) | 12,851,737.50 | 46,938,455.28 | 36,911,443.75 |
| 其他(元) | 1,001,150.02 | 5,335,841.43 | - |
| 营业成本(元) | |||
| 非临床CRO(元) | 261,454,495.92 | 728,136,808.51 | 552,854,251.48 |
| 临床CRO(元) | 8,085,574.29 | 28,008,702.06 | 31,391,759.23 |
| 其他(元) | 540,167.14 | 1,733,785.75 | - |
| 毛利(元) | |||
| 非临床CRO(元) | 99,921,182.72 | 361,258,297.07 | 446,643,198.14 |
| 临床CRO(元) | 4,766,163.21 | 18,929,753.22 | 5,519,684.52 |
| 其他(元) | 460,982.88 | 3,602,055.68 | - |
| 毛利率(%) | |||
| 非临床CRO(%) | 27.65 | 33.16 | 44.69 |
| 临床CRO(%) | 37.09 | 40.33 | 14.95 |
| 其他(%) | 46.05 | 67.51 | - |
| 收入构成(%) | |||
| 非临床CRO(%) | 96.31 | 95.42 | 96.44 |
| 临床CRO(%) | 3.43 | 4.11 | 3.56 |
| 其他(%) | 0.27 | 0.47 | - |
| 毛利构成(%) | |||
| 非临床CRO(%) | 95.03 | 94.13 | 98.78 |
| 临床CRO(%) | 4.53 | 4.93 | 1.22 |
| 其他(%) | 0.44 | 0.94 | - |